The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Related News Articles

Headline
Comments are due Oct. 27 to the Office of Science and Technology Policy on federal regulations that hinder artificial intelligence development, deployment or…
Headline
The AHA urged the Department of Commerce Oct. 17 to take a balanced approach to ensuring dependable and affordable access to personal protective equipment,…
Headline
The Senate Oct. 16 failed for a 10th time to advance the continuing resolution to extend government funding and end the ongoing shutdown. The chamber adjourned…
Headline
The AHA’s Association for Health Care Resource & Materials Management has created a webpage featuring resources on tariffs impacting the health care supply…
Perspective
Public
A highly qualified and engaged workforce is at the heart of America’s health care system. Yet the U.S. faces significant shortages of health care workers…
Headline
The Cybersecurity and Infrastructure Security Agency Oct. 15 released an emergency directive advising federal agencies to take stock of their F5 BIG-IP…